Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
Ongoing legal actions and international reports highlight severe risks linked to weight-loss drugs.
101 trends tracked about this subject — the full history, oldest to newest below.
Ongoing legal actions and international reports highlight severe risks linked to weight-loss drugs.
Current reporting examines how widespread GLP-1 medications are reshaping modern cultural perspectives on body image and weight.
A major clinical trial suggests that diet drinks may be as effective as water for weight loss, challenging common dietary assumptions.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
15 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link weight-loss medications like Ozempic and Wegovy to unexpected hair and nail side effects.
An experimental combination drug from Eli Lilly outperforms Zepbound in a new weight-loss trial.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A major two-year trial from the University of Liverpool suggests diet drinks match water for long-term weight loss and management.
Certified trainers and professional bodybuilders showcase structured walking routines targeting visceral fat and weight loss.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.
Health experts are highlighting specific strength training strategies for individuals utilizing GLP-1 weight-loss medications to manage physical health.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines the intersection of popular weight-loss drugs and cancer outcomes.
Recent scientific research indicates that a new RNA therapy could potentially prevent lean muscle loss during GLP-1 weight loss treatments.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical and lifestyle experts are questioning the long-term safety and efficacy of GLP-1 medications as they transition from clinical tools to consumer drugs.
Eli Lilly plans a 2030 groundbreaking in Houston as weight-loss drug developers line up to tap a lucrative and increasingly competitive market.
As GLP-1 use rises among millions of parents and an increasing number of children, new medical data warns of nutritional risks for youth.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Health insurers in Massachusetts covered 112,000 fewer residents for GLP-1 weight-loss drugs this year.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines rapid weight regain after discontinuing GLP-1 medications like Ozempic, semaglutide, and tirzepatide.
GLP-1 medications face growing attention for unexpected health benefits and wider usage trends beyond weight management.
Recent medical reviews examine how popular weight-loss drugs could transform the clinical treatment of obstructive sleep apnea.
Nutrition and health experts are sharing their personal dessert choices to demonstrate how to balance indulgence with weight loss goals.
A new study suggests a genetic link between the use of GLP-1 weight-loss medications and increased hair loss risks for certain men.
A new experimental weight loss injection has outperformed Mounjaro in a recent study, signaling a potential shift in obesity treatment.
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
New research suggests that consistently logging meals through apps is a primary driver of clinically significant weight loss.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Medical experts and researchers are analyzing whether the rise of GLP-1 drugs signals a turning point for obesity rates in the United States.
Producer Benny Blanco has sparked conversation after revealing the weight loss results of a five-day experiment eating only pizza.
Recent reporting examines the expanding medical landscape surrounding GLP-1 weight loss medications.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage highlights a study showing that a low-fat vegan diet helps individuals lose weight without restricting food.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
Eli Lilly targets the illicit market for its unapproved obesity drug retatrutide through new legal actions.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
A new study reveals that a low-fat vegan diet reduces dietary energy density by nearly a third, facilitating weight loss without conscious calorie cutting.
Actor John Goodman is sparking widespread conversation after photos reveal a dramatic weight loss transformation ahead of his return to the big screen.
John Goodman’s startling 90kg (200‑pound) transformation has fans scrambling for the new look of the 74‑year‑old Roseanne star.